NCT02488005View on ClinicalTrials.gov

The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 17, 2017

Study Completion Date

August 17, 2017

Conditions
Crohn's Disease
Interventions
DEVICE

Ultrasound

An ultrasound of the small bowel will be done by a radiologist or ultrasound technician. Subject should not eat or drink anything (i.e. no food and no water/beverages) for 8 hours prior to their ultrasound appointment

Trial Locations (1)

10029

Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, New York

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02488005 - The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction | Biotech Hunter | Biotech Hunter